InvestorsHub Logo
Followers 13
Posts 2195
Boards Moderated 0
Alias Born 05/30/2012

Re: mjbaker84 post# 160436

Wednesday, 04/21/2021 12:12:28 PM

Wednesday, April 21, 2021 12:12:28 PM

Post# of 233634
The good or bad is always subjective.

However, since they are updating various aspects of the company business it could be they are selling the company, or selling or licensing an indication or indications.

They have repeatedly made mention of the fact that they expect Cytodyn to become an Oncology company and so that is where they see the greatest promise for Cytodyn.

In order to survive and to achieve that goal, they may be selling other indications in order to pay off debt and fund their future. It may be something that shareholders have to vote on or it may be something that just requires full company disclosure in order to cross the T's and dot the I's.

I would say its a selling off of some parts and good for the bottom line and survivability of the company.

There is also the possibility that this was updated and will be presented to potential buyers and was posted to the investor relations portion of the website as a requirement of all shareholders to be given relevant company information.

So, I am not saying its a done deal but rather preparation or part of the process for attempting a deal.

JMHO

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News